Merck Profit Beats Analyst Estimates on Sales of Diabetes Drugs

Merck Profit Beats Analyst Estimates on Sales of Diabetes Drugs

JB Reed/Bloomberg

Merck & Co.'s allergy drug Singulair is pictured in a Cambridge, Massachusetts pharmacy Monday, July 24, 2006.